Log In
BCIQ
Print this Print this
 

RX-0047

  Manage Alerts
Collapse Summary General Information
Company Rexahn Pharmaceuticals Inc.
DescriptionHIF-1alpha inhibitor
Molecular Target Hypoxia-inducible factor 1 alpha (HIF1A) (HIF1-alpha)
Mechanism of ActionHypoxia-inducible factor 1 alpha (HIF-1 alpha) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today